ATE137241T1 - Oligosaccharides - Google Patents

Oligosaccharides

Info

Publication number
ATE137241T1
ATE137241T1 AT93301878T AT93301878T ATE137241T1 AT E137241 T1 ATE137241 T1 AT E137241T1 AT 93301878 T AT93301878 T AT 93301878T AT 93301878 T AT93301878 T AT 93301878T AT E137241 T1 ATE137241 T1 AT E137241T1
Authority
AT
Austria
Prior art keywords
oligosaccharides
cell adhesion
produced
glcnac
inflammation
Prior art date
Application number
AT93301878T
Other languages
English (en)
Inventor
Sau-Chi Betty Yan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE137241T1 publication Critical patent/ATE137241T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Amplifiers (AREA)
AT93301878T 1992-03-12 1993-03-12 Oligosaccharides ATE137241T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84986892A 1992-03-12 1992-03-12

Publications (1)

Publication Number Publication Date
ATE137241T1 true ATE137241T1 (de) 1996-05-15

Family

ID=25306715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93301878T ATE137241T1 (de) 1992-03-12 1993-03-12 Oligosaccharides

Country Status (23)

Country Link
EP (1) EP0565241B1 (de)
JP (1) JP3171506B2 (de)
KR (1) KR930019696A (de)
CN (1) CN1079967A (de)
AT (1) ATE137241T1 (de)
AU (1) AU661762B2 (de)
BR (1) BR9301136A (de)
CA (1) CA2091521A1 (de)
CY (1) CY1947A (de)
CZ (1) CZ39093A3 (de)
DE (1) DE69302317T2 (de)
DK (1) DK0565241T3 (de)
ES (1) ES2088227T3 (de)
FI (1) FI931086L (de)
GR (1) GR3020406T3 (de)
HK (1) HK132396A (de)
HU (1) HUT69613A (de)
IL (1) IL105018A0 (de)
MX (1) MX9301344A (de)
NO (1) NO930890L (de)
NZ (1) NZ247105A (de)
YU (1) YU16993A (de)
ZA (1) ZA931723B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384786B1 (de) * 2001-04-02 2010-01-27 Glycomedics, Inc. Verfahren zur herstellung von oligosaccharidketten
FI20011664L (fi) * 2001-08-17 2003-02-18 Carbion Oy Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
US7943763B2 (en) * 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
AU2003292641B2 (en) * 2002-12-26 2007-11-29 Glytech, Inc. Three-branched sugar-chain asparagine derivatives, the sugar-chain asparagines, the sugar chains, and processes for producing these
JP3884725B2 (ja) 2003-06-03 2007-02-21 三菱電機株式会社 導波管装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009889A (en) * 1987-12-31 1991-04-23 Oklahoma Medical Research Foundation Treatment of dysfunctional vascular endothelium using activated protein C

Also Published As

Publication number Publication date
MX9301344A (es) 1993-09-01
ZA931723B (en) 1994-09-10
CN1079967A (zh) 1993-12-29
GR3020406T3 (en) 1996-09-30
HUT69613A (en) 1995-09-28
DK0565241T3 (da) 1996-05-28
FI931086A0 (fi) 1993-03-11
BR9301136A (pt) 1993-09-28
JPH0625302A (ja) 1994-02-01
EP0565241A1 (de) 1993-10-13
CA2091521A1 (en) 1993-09-13
YU16993A (sh) 1996-02-19
JP3171506B2 (ja) 2001-05-28
CZ39093A3 (en) 1994-03-16
DE69302317T2 (de) 1996-09-19
FI931086A7 (fi) 1993-09-13
EP0565241B1 (de) 1996-04-24
ES2088227T3 (es) 1996-08-01
HK132396A (en) 1996-07-26
IL105018A0 (en) 1993-07-08
FI931086L (fi) 1993-09-13
KR930019696A (ko) 1993-10-18
NO930890D0 (no) 1993-03-11
NZ247105A (en) 1994-11-25
AU661762B2 (en) 1995-08-03
HU9300687D0 (en) 1993-05-28
NO930890L (no) 1993-09-13
CY1947A (en) 1993-03-12
DE69302317D1 (de) 1996-05-30
AU3519993A (en) 1993-09-16

Similar Documents

Publication Publication Date Title
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
NO970155L (no) Kunstig ekstracellulær biologisk matrise samt fremgangsmåte ved fremstilling derav
PH23325A (en) Phenyl carbamates
NO166836C (no) Fremgangsmaate for behandling av et organtransplantat.
ATE125362T1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
IT1150682B (it) Procedimento per la produzione di sostanze prodotte da cellule,particolarmente di anticorpi e simili
AU8564782A (en) Mortars or concretes with acrylate polymer additives
ATE338762T1 (de) Zusammensetzungen und methoden für die verknüpfung von endothelzellen
DE69228159D1 (de) Glasverstärkte gepfropft-verzweigte höhere alpha-olefine
SE8902767D0 (sv) Kemiskt foerfarande
ES2088633T3 (es) Estabilizantes polisiloxanicos que contienen grupos fenol y grupos oxamidicos estericamente impedidos.
DE69302317D1 (de) Oligosaccharides
WO1990007321A3 (en) Lymphocyte receptor homing sequences and their uses
IT8321885A0 (it) Procedimento di isomerizzazione con l'uso di glucosio isomerasi.
DK455586A (da) Kibdelosporangium aridum sk&f-aad-609
IT8567141A0 (it) Procedimento per la coltura di cellule mediante dispersione di gas
EP0723454A4 (de) Für die immun- und cns-therapir nutzbare, neuartige tripeptide
RU93004705A (ru) Олигосахариды, фармацевтическая композиция, применение олигосахаридов
EP0105749A3 (de) Zusammensetzungen verwendbar zum Induzieren einer Immunkörperunterdrückung oder einer Immunregulierung des Immunantwortes zu einem Antigen
Warfel et al. Macrophage membrane glycoproteins that bind Griffonia simplicifolia I‐B4: Effect on cytotoxicity and protein secretion
BR8904681A (pt) Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina
Takahama et al. Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and-stimulating activity.
Wasserman et al. Further studies on the influence of interferon on pokeweed mitogen induced Ig-synthesis in vitro
CHUA AN INVESTIGATION ON THE SURFACE PROPERTIES OF EMBRYONAL CARCINOMA CELLS: FUNCTIONAL AND STRUCTURAL CORRELATIONS TO EARLY EMBRYOS (GLYCOPROTEINS, PREIMPLANTATION, MOUSE)
NAKAJO et al. Cell surface radiolabeling of the carbohydrate moieties of the plasma membrane major glycoprotein of AH-66 hepatoma ascites cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee